MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX) has 32 open-market insider trades by 11 insiders since 2014. The most active filer is Gregory P. Hanson, CFO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| John David Hansen | CEOPres | — | 6 | $506K | 2018-04-02 |
| Paul W. Maffuid | PresVP | — | 6 | $213K | 2018-04-02 |
| Gregory P. Hanson | CFO | — | 7 | $184K | 2018-04-02 |
| Jeffrey V. Ravetch | Dir | — | 1 | $79K | 2017-04-02 |
| Kenneth M. Cohen | Dir | — | 4 | $52K | 2018-04-02 |
| Paul V. Maier | Dir | — | 2 | $42K | 2018-04-02 |
| Philip O. Livingston | CHIEF SCIENCE OFFICER | — | 1 | $36K | 2018-01-12 |
| Jeffrey F. Eisenberg | Dir | — | 1 | $30K | 2018-01-24 |
| Thomas C. Varvaro | Dir | — | 1 | $30K | 2018-04-03 |
| Robert Hoffman | Dir | — | 1 | $24K | 2017-04-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jeffrey F. Eisenberg | Director | Sell | $30K | 2018-01-23 |
| Thomas C. Varvaro | Director | Sell | $30K | 2018-01-23 |
| Paul V. Maier | Director | Sell | $30K | 2018-01-23 |
| Kenneth M. Cohen | Director | Sell | $30K | 2018-01-23 |
| Paul W. Maffuid | President & VP | Sell | $35K | 2018-01-16 |
| John David Hansen | CEO & President | Sell | $109K |
Companies that share insiders with MBVX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2018-01-16 |
| Paul F. Resnick | President & CBO | Sell | $3K | 2018-01-16 |
| Gregory P. Hanson | CFO & SECR | Sell | $39K | 2018-01-16 |
| Paul W. Maffuid | President & VP | Sell | $160K | 2018-01-10 |
| John David Hansen | CEO & President | Sell | $355K | 2018-01-10 |
| Philip O. Livingston | CHIEF SCIENCE OFFICER | Sell | $36K | 2018-01-10 |
| Paul F. Resnick | President & CBO | Sell | $8K | 2018-01-10 |
| Gregory P. Hanson | CFO | Sell | $113K | 2018-01-10 |
| Gregory P. Hanson | CFO & SECR | Buy | $8K | 2017-05-19 |
| Paul W. Maffuid | President & VP | Buy | $5K | 2017-05-19 |